ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Medical School Deans Biggest Enemy Of Cancer Program, Saunders Says; House Oks Line Item

May 16, 1980

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

March 20, 1998

Human Genome Consortium Completes “Working Draft”.

June 30, 2000

GM Foundation Awards Prizes

June 13, 2003

FASEB: Focus on Research Funding, Not PR

June 14, 2013